V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007899 | 280005168 | 1.65 | 77 | Palliative (P) | 2015-12-02 | 2015-12-03 | PACLITAXEL | N | N | 280025763 | PACLITAXEL |
| 280007900 | 280008731 | null | 75 | Palliative (P) | 2016-01-04 | 2016-01-22 | DOXORUBICIN | null | null | 280025764 | DOXORUBICIN |
| 280007901 | 280005169 | 1.68 | null | Adjuvant (A) | 2015-06-11 | 2015-06-11 | CARBOPLATIN + RT | N | Y | 280025765 | CARBOPLATIN + RT |
| 280007902 | 280005169 | 1.7 | null | Curative (C) | 2018-01-06 | 2018-01-22 | Cisplatin | N | Y | 280025765 | CISPLATIN |
| 280007903 | 280005169 | 1.8 | 87.5 | Palliative (P) | 2016-07-15 | 2016-09-05 | Cetuximab + Radiotherapy Load | N | Y | 280025765 | CETUXIMAB + RT |
| 280007904 | 280010436 | 0 | 10.55 | Disease modification (D) | 2013-11-11 | 2014-12-18 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025771 | RMS 2005 TRIAL |
| 280007905 | 280010436 | 1.7 | 100 | Palliative (P) | 2016-04-03 | 2016-04-09 | Paclitaxel 7 day | 2 | N | 280025771 | PACLITAXEL |
| 280007906 | 280010436 | 1.62 | 68.4 | Curative (C) | 2016-07-04 | 2016-07-24 | CARBOPLATIN + RT | 02 | Y | 280025771 | CARBOPLATIN + RT |
| 280007907 | 280005171 | 1.68 | 54.7 | Curative (C) | 2017-05-26 | 2017-05-27 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | 280025782 | RMS 2005 TRIAL |
| 280007908 | 280005172 | null | 95.3 | Curative (C) | 2014-12-21 | 2014-12-30 | CARBOPLATIN + RT | N | N | 280025785 | CARBOPLATIN + RT |
| 280007909 | 280005173 | 1.14 | 91.9 | Curative (C) | 2016-01-09 | 2016-02-19 | IVA | 02 | N | 280025789 | IVA |
| 280007910 | 280005174 | 1.88 | 44.5 | Curative (C) | 2017-04-11 | 2017-04-23 | CARBOPLATIN + RT | N | Y | 280025789 | CARBOPLATIN + RT |
| 280007911 | 280005175 | null | 91.4 | Curative (C) | 2014-02-04 | 2014-02-04 | Cetuximab + Radiotherapy Maint | N | Y | 280025792 | CETUXIMAB + RT |
| 280007912 | 280005175 | 1.71 | 55 | Disease modification (D) | 2015-07-13 | 2016-09-29 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280025792 | RMS 2005 TRIAL |
| 280007913 | 280005176 | 1.52 | 70.9 | Palliative (P) | 2016-11-17 | 2017-02-15 | STS Rhabdomyosarcoma RMS 2005 IVA | N | null | 280025794 | IVA |
| 280007914 | 280008739 | null | 68 | Curative (C) | 2014-02-02 | 2015-09-23 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025794 | RMS 2005 TRIAL |
| 280007915 | 280005183 | 1.64 | 75.4 | Palliative (P) | 2015-09-17 | 2015-09-21 | Paclitaxel 7 day | N | N | 280025801 | PACLITAXEL |
| 280007916 | 280005183 | 1.7 | 86.45 | Palliative (P) | 2015-03-11 | 2015-03-25 | Doxorubin 50mg/m2 | N | N | 280025801 | DOXORUBICIN |
| 280007917 | 280005186 | 1.63 | 68.75 | Palliative (P) | null | 2017-04-30 | DOXORUBICIN | N | N | 280025812 | DOXORUBICIN |
| 280007918 | 280005187 | null | 95 | Palliative (P) | 2015-12-24 | 2016-03-18 | Cisplatin | N | null | 280025813 | CISPLATIN |
| 280007919 | 280005187 | 1.74 | 90 | Palliative (P) | 2014-03-25 | 2014-03-25 | Cisplatin 7 day | 02 | Y | 280025813 | CISPLATIN |
| 280007920 | 280010440 | 1.7 | 11.6 | Curative (C) | null | 2015-05-31 | Cetuximab + Radiotherapy Maint | N | Y | 280025815 | CETUXIMAB + RT |
| 280007921 | 280010440 | 1.71 | 55.7 | Adjuvant (A) | 2015-06-13 | 2015-06-13 | CARBOPLATIN + RT | 02 | N | 280025815 | CARBOPLATIN + RT |
| 280007922 | 280005188 | 1.74 | 28.1 | Palliative (P) | 2015-11-25 | 2016-02-17 | Paclitaxel 7 day | 02 | N | 280025818 | PACLITAXEL |
| 280007923 | 280005188 | 1.73 | 38.1 | Palliative (P) | 2016-09-09 | 2016-09-15 | Ifosfamide | 02 | N | 280025818 | IFOSFAMIDE |
| 280007924 | 280005190 | 1.7 | 113.9 | Palliative (P) | 2013-02-15 | 2013-03-04 | Doxorubin 50mg/m2 | N | N | 280025821 | DOXORUBICIN |
| 280007925 | 280005193 | 1.73 | 113.9 | Adjuvant (A) | 2014-06-03 | 2014-08-20 | CARBOPLATIN + RT | 02 | Y | 280025822 | CARBOPLATIN + RT |
| 280007926 | 280008746 | 1.78 | 31 | null | 2014-10-17 | 2014-10-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280025823 | PACLITAXEL |
| 280007927 | 280008746 | 1.84 | 81.6 | Palliative (P) | 2015-01-27 | 2015-01-29 | Ifosfamide | 02 | N | 280025823 | IFOSFAMIDE |
| 280007928 | 280005194 | 1.7 | 77 | Adjuvant (A) | 2013-07-29 | 2014-02-01 | Doxorubicin 75mg/m2 | 02 | N | 280025828 | DOXORUBICIN |
| 280007929 | 280011277 | 1.67 | 59 | Neo-adjuvant (N) | 2014-03-25 | 2015-08-27 | Doxorubicin 75mg/m2 | 02 | N | 280025832 | DOXORUBICIN |
| 280007930 | 280008748 | 0 | 48.1 | Adjuvant (A) | 2014-05-28 | 2014-07-30 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280025833 | IVA |
| 280007931 | 280005196 | 1.6 | null | Curative (C) | 2016-07-15 | 2016-08-22 | Cetuximab + Radiotherapy Maint | N | Y | 280025836 | CETUXIMAB + RT |
| 280007932 | 280005196 | 1.74 | null | Palliative (P) | 2015-07-28 | 2015-11-27 | Paclitaxel 7 day | Y | N | 280025836 | PACLITAXEL |
| 280007933 | 280005197 | 1.53 | 99.8 | Palliative (P) | 2014-09-08 | 2014-09-26 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | 280025837 | RMS 2005 TRIAL |
| 280007934 | 280008751 | 1.58 | 72.2 | Palliative (P) | 2014-03-01 | 2014-10-23 | DOXORUBICIN | 02 | N | 280025841 | DOXORUBICIN |
| 280007935 | 280005199 | 1.74 | null | Palliative (P) | 2015-06-29 | 2015-06-29 | Cisplatin | N | null | 280025842 | CISPLATIN |
| 280007936 | 280005200 | 1.75 | 96.5 | Curative (C) | 2013-11-25 | 2013-12-12 | Cisplatin | N | Y | 280025848 | CISPLATIN |
| 280007937 | 280005200 | 1.8 | null | Palliative (P) | 2017-03-23 | 2017-05-10 | Cetuximab + Radiotherapy Maint | N | Y | 280025848 | CETUXIMAB + RT |
| 280007938 | 280005200 | 1.76 | 102 | Palliative (P) | 2016-12-03 | 2017-07-08 | Ifosfamide | N | N | 280025848 | IFOSFAMIDE |
| 280007939 | 280005203 | 1.79 | 72.6 | Curative (C) | 2017-12-03 | 2017-12-03 | Cisplatin | N | Y | 280025860 | CISPLATIN |
| 280007940 | 280008753 | 1.83 | 88.1 | Palliative (P) | 2015-09-15 | 2015-10-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280025861 | PACLITAXEL |
| 280007941 | 280005204 | 1.79 | null | Palliative (P) | 2016-09-09 | 2016-09-09 | Cisplatin | N | N | 280025867 | CISPLATIN |
| 280007942 | 280005205 | 0 | 46.2 | Palliative (P) | 2015-09-03 | 2015-09-03 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280025869 | IVA |
| 280007943 | 280005205 | 1.8 | 91.4 | Curative (C) | 2017-04-15 | 2017-05-10 | Cisplatin 7 day | N | N | 280025869 | CISPLATIN |
| 280007944 | 280005205 | 1.85 | 63.9 | Palliative (P) | 2017-08-29 | 2017-08-29 | DOXORUBICIN | N | N | 280025869 | DOXORUBICIN |
| 280007945 | 280005205 | 1.63 | 116 | Palliative (P) | 2017-09-24 | 2017-09-24 | DOXORUBICIN | null | null | 280025869 | DOXORUBICIN |
| 280007946 | 280005206 | null | 110 | Curative (C) | 2016-04-26 | 2016-04-26 | CARBOPLATIN + RT | N | Y | 280025874 | CARBOPLATIN + RT |
| 280007947 | 280005207 | null | 79.8 | Palliative (P) | 2014-02-27 | 2014-02-27 | DOXORUBICIN | N | N | 280025877 | DOXORUBICIN |
| 280007948 | 280005207 | 1.74 | null | Neo-adjuvant (N) | 2015-08-19 | 2015-10-04 | DOXORUBICIN | 02 | N | 280025877 | DOXORUBICIN |